Intravitreal Injection of Proinsulin-Loaded Microspheres Delays Photoreceptor Cell Death and Vision Loss in therd10Mouse Model of Retinitis Pigmentosa
Author(s) -
Carolina Isiegas,
Jorge A. Marinich-Madzarevich,
Miguel Marchena,
José María Ruiz,
María J. Cano,
Pedro de la Villa,
Catalina HernándezSánchez,
Enrique J. de la Rosa,
Flora de Pablo
Publication year - 2016
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.16-19300
Subject(s) - retinitis pigmentosa , outer nuclear layer , photoreceptor cell , electroretinography , retina , retinal , retinal degeneration , neuroprotection , biology , ophthalmology , medicine , pharmacology , neuroscience
The induction of proinsulin expression by transgenesis or intramuscular gene therapy has been shown previously to retard retinal degeneration in mouse and rat models of retinitis pigmentosa (RP), a group of inherited conditions that result in visual impairment. We investigated whether intraocular treatment with biodegradable poly (lactic-co-glycolic) acid microspheres (PLGA-MS) loaded with proinsulin has cellular and functional neuroprotective effects in the retina.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom